our mission

To develop and commercialize self-administered parenteral medicines that optimize clinical benefits with enhanced cost effective health outcomes

news / press releases

  • 25 February 2015

    Antares Pharma Announces Positive Top-line Pharmakcokinetic Results From the Quickshot Phase 3 Study in Testosterone Deficient Men
  • 23 February 2015

    Antares Pharma to Present at the Cowen and Company 35th Annual Healthcare Conference
  • 18 February 2015

    Antares Pharma to Present at the 2015 RBC Capital Markets' Global Healthcare Conference
  • 26 January 2015

    Antares Pharma Provides Regulatory Update on Sumatriptan Injection USP
  • 13 January 2015

    Antares Pharma Announces Update to Quick Shot Testosterone Program
  • 8 January 2015

    Antares Pharma to Present at the 33rd Annual JP Morgan Healthcare Conference

latest products & technology

 

Otrexup (methotrexate) injection for subcutaneous use only.

Learn More >>